Kim, Y., Kim, H., Park, D., Lee, H., Lee, Y. S., Choe, J., . . . Jeoung, D. (2017). The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1. Oncotarget.
Citação norma ChicagoKim, Youngmi, Hyuna Kim, Deokbum Park, Hansoo Lee, Yun Sil Lee, Jongseon Choe, Young Myeong Kim, Doyong Jeon, and Dooil Jeoung. "The Pentapeptide Gly-Thr-Gly-Lys-Thr Confers Sensitivity to Anti-cancer Drugs By Inhibition of CAGE Binding to GSK3β and Decreasing the Expression of CyclinD1." Oncotarget 2017.
ציטוט MLAKim, Youngmi, et al. "The Pentapeptide Gly-Thr-Gly-Lys-Thr Confers Sensitivity to Anti-cancer Drugs By Inhibition of CAGE Binding to GSK3β and Decreasing the Expression of CyclinD1." Oncotarget 2017.